Extract

The primary objective of this study is to obtain data regarding the safety of olipudase alfa in patients with acid sphingomyelinase deficiency (ASMD) who are exposed to long-term treatment with olipudase alfa

Inclusion criteria

• Patients with acid sphingomyelinase deficiency (Niemann-Pick Type B disease)

Links

• ictrp
• euctr